Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #2190 on Sorrento Therapeutics Inc (SRNE)
Jtech
05/15/20 3:55 PM
#2196 RE: Jtech #2190
If the Phase I trial starts by the beginning of July, they will know within a week or two whether the antibody is having an effect. If it is effective and safe in the patients, they would expect to start a larger Phase II trial in August or possibly September. “Hopefully we will be able to submit for approval before the end of the year or beginning of next year,” Brunswick added.